Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,176

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes

Gnjidic, Danijela, Hilmer, Sarah N., Blyth, Fiona M., Naganathan, Vasi, Waite, Louise, Seibel, Markus J., McLachlan, Andrew J., Cumming, Robert G., Handelsman, David J., Le Couteur, David G.·2012·Journal of Clinical Epidemiology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jclinepi.2012.02.018

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 30

  1. Hilmer, 2007, Clinical pharmacology in the geriatric patient, Fundam Clin Pharmacol, 21, 217, 10.1111/j.1472-8206.2007.00473.x · DOI · Paper page
  2. McLean, 2004, Aging biology and geriatric clinical pharmacology, Pharmacol Rev, 56, 163, 10.1124/pr.56.2.4 · DOI · Paper page
  3. Le Couteur, 2012, Aging, drugs and drug metabolism, J Gerontol A Biol Sci Med Sci, 67, 137, 10.1093/gerona/glr084 · DOI
  4. Hilmer, 2009, The effects of polypharmacy in older adults, Clin Pharmacol Ther, 85, 86, 10.1038/clpt.2008.224 · DOI · Paper page
  5. Hilmer, 2012, Pharmacoepidemiology in the postmarketing assessment of the safety and efficacy of drugs in older adults, J Gerontol A Biol Sci Med Sci, 67, 181, 10.1093/gerona/glr066 · DOI
  6. Shoair, 2011, Medication-related dizziness in the older adult, Otolaryngol Clin North Am, 44, 455, 10.1016/j.otc.2011.01.014 · DOI
  7. Frazier, 2005, Health outcomes and polypharmacy in elderly individuals: an integrated literature review, J Gerontol Nurs, 31, 4, 10.3928/0098-9134-20050901-04 · DOI · Paper page
  8. Jensen, 2001, Screening for hospitalization and nutritional risks among community-dwelling older persons, Am J Clin Nutr, 74, 201, 10.1093/ajcn/74.2.201 · DOI
  9. Veehof, 1999, Adverse drug reactions and polypharmacy in the elderly in general practice, Eur J Clin Pharmacol, 55, 533, 10.1007/s002280050669 · DOI
  10. Corsinovi, 2009, Predictors of falls and hospitalization outcomes in elderly patients admitted to an acute geriatric unit, Arch Gerontol Geriatr, 49, 142, 10.1016/j.archger.2008.06.004 · DOI
  11. Gnjidic, 2012, High risk prescribing and incidence of frailty among older community-dwelling men, Clin Pharmacol Ther, 91, 521, 10.1038/clpt.2011.258 · DOI · Paper page
  12. Haider, 2009, The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people, J Am Geriatr Soc, 57, 62, 10.1111/j.1532-5415.2008.02040.x · DOI · Paper page
  13. Jyrkka, 2006, Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+Study, Eur J Clin Pharmacol, 62, 151, 10.1007/s00228-005-0079-6 · DOI
  14. O’Mahony, 2011, Pharmacotherapy at the end-of-life, Age Ageing, 40, 419, 10.1093/ageing/afr059 · DOI
  15. Cumming, 2009, Cohort Profile: the Concord Health and Ageing in Men Project (CHAMP), Int J Epidemiol, 38, 374, 10.1093/ije/dyn071 · DOI
  16. Rochat, 2010, Frailty and use of health and community services by community-dwelling older men: the Concord Health and Ageing in Men Project, Age Ageing, 39, 228, 10.1093/ageing/afp257 · DOI
  17. Blyth, 2008, Pain, frailty and comorbidity on older men: the CHAMP study, Pain, 140, 224, 10.1016/j.pain.2008.08.011 · DOI
  18. Washburn, 1993, The Physical Activity Scale for the Elderly (PASE): development and evaluation, J Clin Epidemiol, 46, 153, 10.1016/0895-4356(93)90053-4 · DOI · Paper page
  19. Katz, 1970, Progress in development of the index of ADL, Gerontologist, 10, 20, 10.1093/geront/10.1_Part_1.20 · DOI · Paper page
  20. Jorm, 1994, A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation, Psychol Med, 24, 145, 10.1017/S003329170002691X · DOI · Paper page
  21. Petersen, 2004, Mild cognitive impairment as a diagnostic entity, J Intern Med, 256, 183, 10.1111/j.1365-2796.2004.01388.x · DOI · Paper page
  22. Roman, 1993, Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop, Neurology, 43, 250, 10.1212/WNL.43.2.250 · DOI · Paper page
  23. McKhann, 1984, Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
  24. Espino, 2006, Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE Study, J Gerontol A Biol Sci Med Sci, 61, 170, 10.1093/gerona/61.2.170 · DOI
  25. Blake, 1988, Falls by elderly people at home: prevalence and associated factors, Age Ageing, 17, 365, 10.1093/ageing/17.6.365 · DOI · Paper page
  26. Ziere, 2006, Polypharmacy and falls in the middle age and elderly population, Br J Clin Pharmacol, 61, 218, 10.1111/j.1365-2125.2005.02543.x · DOI · Paper page
  27. Neutel, 2002, Medication use and risk of falls, Pharmacoepidemiol Drug Saf, 11, 97, 10.1002/pds.686 · DOI · Paper page
  28. Tinetti, 1995, Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes, JAMA, 273, 1348, 10.1001/jama.1995.03520410042024 · DOI · Paper page
  29. Pencina, 2008, Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond, Stat Med, 27, 157, 10.1002/sim.2929 · DOI · Paper page
  30. Cook, 2007, Use and misuse of the receiver operating characteristic curve in risk prediction, Circulation, 115, 928, 10.1161/CIRCULATIONAHA.106.672402 · DOI · Paper page

Cited by

See all 1,176

Metadata

Authors
Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Waite, L., Seibel, M. J., McLachlan, A. J., Cumming, R. G., Handelsman, D. J., & Le Couteur, D. G.
Venue
Journal of Clinical Epidemiology
Publisher
Elsevier BV
Published
2012-09
Volume
65
Issue
9
Pages
989-995
ISSN
0895-4356 (ISSN-L)
OpenAlex
W1963867953
Cited by
1,176
References
9
FWCI
17.46
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
Australian National Health and Medical Research Council (301916)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. https://app.cochat.ai/papers/10.1016/j.jclinepi.2012.02.018
The paper
Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Waite, L., Seibel, M. J., McLachlan, A. J., Cumming, R. G., Handelsman, D. J., & Le Couteur, D. G. (2012). Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. Journal of Clinical Epidemiology. https://doi.org/10.1016/j.jclinepi.2012.02.018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.